Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab

Roche CEO Thomas Schinecker said during the company’s Q3 call that it is “not done” with deals—a promise he delivered on with Tuesday’s solid tumor pact with AI-focused Caris Life Sciences.